A global study looks into the prevalence of neurological symptoms in patients with COVID-19.
The route of all COVID-19 evil: RNA
RNA-related processes that are key to the biology of the cell are at risk during coronavirus infections.
One in five people worldwide at risk of severe COVID-19
A new study estimates that one in five people worldwide have an underlying health condition that could increase their risk of severe COVID-19 if infected.
What we can learn from the social nature of COVID-19 and climate change?
COVID-19, like climate change, is a complex social problem that will require social scientific knowledge to understand its full and lasting impact impact.
UN: Falling clean energy costs can provide opportunity to boost climate action during COVID-19 recovery
If governments take advantage of the ever-falling price tag of renewables to put clean energy at the heart of COVID-19 economic recovery, they can take a big step towards a healthy world, which is the best insurance policy against global pandemics.
Lessons learned during the COVID-19 pandemic
Exploring the unique ethical dilemmas raised by the COVID‐19 outbreak and how they have affected multiple sectors of society, both nationally and globally.
Roadblocks in AI identified by the COVID-19 pandemic
The current pandemic has provided an opportunity to observe the resilience of every link in the healthcare chain, and AI has appeared to have given in.
Scientists aim gene-targeting breakthrough against COVID-19
Lipitoids, which self-assemble with DNA and RNA, could serve as cellular delivery systems for antiviral therapies that prevent COVID-19 and other coronavirus infections.
How likely is it that COVID-19 will be a seasonal illness?
SARS-CoV-2 transmission appears to be affected by humidity, but experts warn that declines in summer months will not slow transmission enough to make a big dent.
No evidence of benefit from chloroquine and hydroxychloroquine in COVID-19 patients
A study that analyzed data from nearly 15 000 patients with COVID-19 receiving four combinations of chloroquine, hydroxychloroquine, and antibiotics indicates the drug regimen may be doing more harm than good.